The diabetic retinal examination is a specialized medical procedure aimed at assessing the eye health of patients with diabetes, primarily for early detection of diabetic retinopathy. This condition results from prolonged high blood sugar damaging the retinal blood vessels, which can lead to vision impairment or even blindness. The examination involves observing the retinal structure with specialized instruments, evaluating the severity of the lesions, and formulating appropriate treatment strategies.
The core goal is early diagnosis to prevent disease progression. Even asymptomatic diabetic patients should undergo regular examinations, as early lesions often do not cause noticeable visual abnormalities. Through periodic monitoring, physicians can intervene promptly, significantly reducing the risk of blindness.
Common examination types include fundus examination with pupil dilation, optical coherence tomography (OCT), and fundus photography. Fundus examination with dilating eye drops allows physicians to directly observe changes in the retinal microvasculature; OCT uses laser scanning to generate high-resolution cross-sectional images of the retina, accurately assessing edema or tissue abnormalities.
Fundus angiography can track microvascular leakage or neovascularization, while en face OCT provides three-dimensional visualization of lesions. These techniques are non-invasive and highly safe but require operation by an ophthalmology specialist to ensure diagnostic accuracy.
All diabetic patients should begin examinations immediately after diagnosis. Type 1 diabetics should have their first exam within 5 years of diagnosis, while Type 2 diabetics should be examined immediately upon diagnosis. If retinal hemorrhages, macular edema, or neovascularization are detected, follow-up frequency should increase to every 3 to 6 months.
Patients with diabetes combined with hypertension, hyperlipidemia, or pregnancy have a higher risk of retinal lesions and require more frequent examinations. Additionally, patients who have undergone retinal laser therapy or anti-VEGF injections should have follow-ups every 3 to 6 months to evaluate treatment efficacy.
Before the examination, cycloplegic agents (such as atropine) and mydriatic drops (such as tropicamide) are used to dilate the pupils, a process that takes approximately 15-30 minutes. OCT requires the patient to fixate on a specific target, with each scan taking about 5 minutes. The frequency of examinations is adjusted based on disease stage: mild lesions annually, moderate to severe lesions every 3-6 months.
Within 2-4 hours after the examination, patients may experience photophobia or near vision blurring; it is recommended to be accompanied when returning home. If mydriatic drops are used, avoid driving or operating machinery until vision normalizes.
Compared to traditional visual acuity tests, this examination can detect abnormalities in the deeper retinal structures. Statistics show that regular screening can reduce the risk of blindness in diabetic patients by 95%, while also decreasing the incidence of complications such as vitreous hemorrhage.
Mydriasis may cause transient discomfort, including photophobia, near vision blur, and slight intraocular pressure elevation, usually resolving within 4-6 hours. Rarely, patients may have allergic reactions to mydriatic drops, presenting as skin itching or breathing difficulties, requiring immediate discontinuation and medical attention.
Severe contraindications include patients with acute narrow-angle glaucoma, who must not use mydriatic agents. Although the procedure is non-invasive, patients with severe cataracts obstructing the visual field may have compromised results, necessitating surgical treatment before further assessment.
Patients should avoid self-administration of mydriatic or miotic agents 3 days prior to the examination and bring current blood glucose control data for reference. Pregnant women in the later stages should exercise caution when using mydriatic agents, as some medications may affect uterine smooth muscle.
Absolute contraindications include:
Examination results are correlated with systemic blood glucose control indices (such as HbA1c) to help physicians adjust insulin or oral hypoglycemic agents. If macular edema is detected, combined treatment with anti-VEGF injections or laser photocoagulation may be necessary.
Closely related to cataract surgery planning, patients with severe retinal lesions need prior ocular treatment before undergoing cataract removal. Regular examination data can be shared with internists to facilitate comprehensive management of diabetic complications.
Multicenter studies show that in patients followed every 6 months, 87% of macular edema can be detected before symptoms appear. The American Diabetes Association (ADA) recommends regular screening to reduce the risk of severe vision loss by 58%.
The 2020 New England Journal of Medicine tracked 12,000 patients and found that those undergoing regular examinations received laser treatment on average 14 months earlier, effectively delaying disease progression. Digital AI-assisted systems can further improve lesion detection rates to 92%.
Home vision testing devices only detect central vision and cannot identify peripheral retinal lesions. Automated retinal cameras can perform preliminary screening but cannot replace physical assessment and complex lesion diagnosis by a physician.
Self-funded remote retinal imaging analysis services can serve as supplements but require offline follow-up. None of these alternatives can provide immediate pathological tissue analysis or treatment recommendations; professional ophthalmologic diagnosis remains essential.
Usually, there is no need to discontinue medication, but it is recommended to consult with the attending physician beforehand. The doctor will assess blood sugar control and decide whether to adjust medication timing or dosage to prevent discomfort caused by hypoglycemia during the examination. Patients should eat normally on the day of the exam to avoid hypoglycemia from fasting.
What can be done if discomfort occurs during dilation?The mydriatic drops may cause temporary photophobia or near vision blur, which is normal. After the exam, wearing sunglasses can help reduce discomfort, and avoid driving alone. If symptoms persist beyond 6 hours or severe headache occurs, seek medical attention immediately.
How soon can routine activities resume after fundus examination?Most activities can be resumed immediately after the exam, but the effects of dilation may impair near vision for 2-8 hours. It is advised to avoid tasks requiring precise vision (such as driving or operating machinery) within 2 hours post-exam. If lesions are detected that require laser treatment, follow the doctor’s instructions for subsequent arrangements.
How should patients with diabetic retinopathy schedule follow-up examinations?Patients with no lesions should have a comprehensive eye exam at least once a year. Those with mild lesions should be followed every 6 months, and severe lesions or post-treatment patients every 3 months. Pregnant women with diabetes should increase examination frequency early in pregnancy, as pregnancy may accelerate lesion progression.
What are the differences between non-dilated fundus photography and traditional dilation examination?Non-dilated examinations reduce photophobia discomfort but may not fully visualize peripheral retina due to smaller pupils; traditional dilation provides a brief discomfort but allows comprehensive assessment of lesions. The choice depends on the patient’s pupil condition, disease severity, and equipment availability, as determined by the physician.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
